• Profile
Close

Effect of etanercept on the success of assisted reproductive technology in patients with endometrioma

Gynecologic and Obstetric Investigation Nov 30, 2017

Önalan G, et al. - Researchers here assessed the effects of a tumor necrosis factor inhibitor (etanercept) on pregnancy outcomes in patients with endometrioma who were treated with assisted reproductive technology. Findings suggested that etanercept could be a new non-hormonal therapy that might be an adjunct to treatment of infertile women with endometrioma. However, full clarification regarding the safety of etanercept on embryos and fetuses requires exploration.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay